Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib-Reference-Cited by-同舟云学术

Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib

Published:2020-10-20 Issue:1 Volume:27 Page:34-42
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Rosen Ezra Y.,Johnson Melissa L.,Clifford Sarah E.,Somwar Romel,Kherani Jennifer F.,Son Jieun^ORCID,Bertram Arrien A.,Davare Monika A.,Gladstone Eric^ORCID,Ivanova Elena V.,Henry Dahlia N.^ORCID,Kelley Elaine M.^ORCID,Lin Mika,Milan Marina S.D.,Nair Binoj C.,Olek Elizabeth A.^ORCID,Scanlon Jenna E.,Vojnic Morana^ORCID,Ebata Kevin,Hechtman Jaclyn F.,Li Bob T.^ORCID,Sholl Lynette M.,Taylor Barry S.,Ladanyi Marc,Jänne Pasi A.,Rothenberg S. Michael,Drilon Alexander^ORCID,Oxnard Geoffrey R.

Funder

NCI

NIH

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fundamentals and recent advances in the evaluation and management of medullary thyroid carcinoma;Molecular and Cellular Endocrinology;2024-10

2. Combination of MDM2 and Targeted Kinase Inhibitors Results in Prolonged Tumor Control in Lung Adenocarcinomas With Oncogenic Tyrosine Kinase Drivers and MDM2 Amplification;JCO Precision Oncology;2024-09

3. Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies;MedComm;2024-08-24

4. Recent progress of small-molecule of RET inhibitors against Non-small cell lung cancer;AAPS Open;2024-06-17

5. Insights into highly selective RET inhibitors in medullary thyroid cancer;Current Opinion in Endocrine and Metabolic Research;2024-06